NPI: 1033283445 · MIAMI, FL 33128 · Multi-Specialty Clinic/Center · NPI assigned 11/17/2006
Authorized official KNIGHT, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | KNIGHT, MARK (CHIEF FINANCIAL OFFICER) |
| Parent Organization | PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY |
| NPI Enumeration Date | 11/17/2006 |
Other providers sharing the same authorized official: KNIGHT, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,442 | $48K |
| 2019 | 5,676 | $169K |
| 2020 | 3,739 | $113K |
| 2021 | 5,717 | $201K |
| 2022 | 6,010 | $208K |
| 2023 | 3,002 | $114K |
| 2024 | 2,451 | $110K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5,234 | 4,657 | $320K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,551 | 3,108 | $271K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3,621 | 3,263 | $205K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 493 | 432 | $41K |
| 81003 | 3,361 | 2,368 | $36K | |
| 99215 | Prolong outpt/office vis | 329 | 302 | $27K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,432 | 1,602 | $19K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 286 | 274 | $16K |
| 84703 | 643 | 565 | $10K | |
| 86803 | 503 | 471 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | 376 | 333 | $4K |
| 99205 | Prolong outpt/office vis | 28 | 27 | $3K |
| 80053 | Comprehensive metabolic panel | 270 | 220 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 27 | 27 | $2K |
| 80061 | Lipid panel | 276 | 233 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 156 | 140 | $885.51 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,388 | 1,218 | $592.57 |
| 90677 | 103 | 101 | $381.07 | |
| 81001 | 338 | 294 | $261.55 | |
| 0064U | 346 | 316 | $142.84 | |
| 84439 | 49 | 38 | $131.27 | |
| 86900 | 148 | 142 | $97.58 | |
| 82950 | 39 | 39 | $94.50 | |
| 88142 | 200 | 184 | $91.95 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 684 | 577 | $73.69 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 55 | 54 | $31.34 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 660 | 576 | $22.10 |
| 87625 | 55 | 54 | $15.67 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 131 | 124 | $0.00 |
| 90670 | 521 | 501 | $0.00 | |
| 84702 | 105 | 84 | $0.00 | |
| 90671 | 47 | 47 | $0.00 | |
| 85660 | 178 | 170 | $0.00 | |
| 86780 | 235 | 198 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 473 | 442 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 115 | 111 | $0.00 |
| 90744 | 41 | 40 | $0.00 | |
| 87070 | 72 | 69 | $0.00 | |
| 86762 | 212 | 200 | $0.00 | |
| 82105 | 25 | 24 | $0.00 | |
| 90697 | 103 | 96 | $0.00 | |
| 86901 | 148 | 142 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 234 | 216 | $0.00 |
| 87340 | 521 | 487 | $0.00 | |
| 86850 | 149 | 141 | $0.00 | |
| 90686 | 60 | 57 | $0.00 | |
| 82677 | 16 | 12 | $0.00 |